Tagged with S

Puerto Rico Lucy Crespo, CEO of the Puerto Rico Science, Technology & Research Trust, takes stock of the Trust’s main achievements since outlining its strategic plan in 2015. She also highlights her future ambitions of strengthening the Puerto Rican entrepreneurship and research ecosystem, through start-up acceleration programs and grants, with the ultimate…

China Global medical aesthetics market leader Allergan is investing heavily in the Chinese city of Chengdu and has launched a number of initiatives there, including a global consumer experience centre, an R&D-focused innovation centre, and a brand awareness drive for both consumers and potential future employees.   The Chinese medical aesthetics…

Cannabis PharmaBoardroom’s new InFocus section examines the fast-growing and lucrative global medical cannabis market, touching on investment opportunities, regulatory hurdles, regional hotspots and more.   With cannabis and cannabinoid treatments increasingly accepted as legitimate and effective medicines for a wide variety of conditions from chronic pain to mental disorders and even…

Asia In the past year, PharmaBoardroom has spoken to several of the most impressive female pharma leaders working in Asia today. These women are breaking new ground and managing some of Big Pharma’s most important global affiliates. Here, five of Asian pharma’s top female executives give exclusive insights into their successes…

Taiwan Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to share his mission to fulfil CEO Lars Fruergaard Jørgensen’s strategy of expanding beyond being a leader of diabetes at the…

Puerto Rico After climbing through the ranks from sales representative to leading business units at Eli Lilly Canada, François Gilbert took the reins of Eli Lilly’s Puerto Rican affiliate last year. Among other things, he shares the reasons why Eli Lilly invests in strong commercial capabilities and clinical operations on the island,…

Taiwan Dr Fuh-Sheng Shieu, president of National Chung Hsing University, elaborates on his ambitions to further NCHU’s positioning as one of Taiwan’s most impactful research universities. He goes on to highlight NCHU’s capacity to nurture translational research projects, which through the university’s strong academia-industry collaboration, achieve commercial success. Dr Shieu also…

China Dr Li Shuai of pain- and CNS-focused Chinese biotech SIMR outlines the history of the company, the unmet medical needs it is seeking to address, its partnership strategy, and the complexities of attracting and retaining talent in the highly competitive Chinese market.   In 2014, my first angel investor actually…

Taiwan Medimaging Integrated Solution Inc (MiiS) originated from the incubation center at the National Chiao Tung University (NCTU), Taiwan. MiiS started its business primarily based on the foundation of innovation, and their main product is the Horus Scope used for diagnostic imaging. The Founder & CEO, Dr. Stefan Cheng holds a…

Sweden Having more than 20 years’ experience in the beverage industry, Isabelle Ducellier was appointed as the CEO of Swedish probiotics company BioGaia in November 2018. Here, Ducellier highlights her goal of moving the company into the B2B/B2C sector, regulatory obstacles for clinically proven probiotics and BioGaia’s long term strategy.  …

Sweden Johan Wäborg, General Manager Nordic countries at Actelion, shares the importance of Sweden for the group due to its world-class healthcare system and community of experts as well as its national quality and health registries which make the country an ideal environment for early launches and follow-up of treatment outcomes.…

Puerto Rico Charil Pabón, Owner & President of Pharma Consulting Corporation (PCC), explains how the decreasing demand for validation services in Puerto Rico prompted the company to expand in new business areas such as the design and installation of laboratory, where PCC is now market leader, as well as enter new markets…